Documents and Charters The Board of Directors of Entrada (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations. Governance Documents Code of Business Conduct Corporate Governance Guidelines Committee Charters Audit Committee Charter Compensation Committee Charter Nominating and Corporate Governance Committee Charter Management Team Dipal Doshi President and Chief Executive Officer Natarajan Sethuraman, PhD Chief Scientific Officer Nerissa C. Kreher, MD Chief Medical Officer Nathan J. Dowden Chief Operating Officer Kory Wentworth, CPA Chief Financial Officer Kerry Robert Senior Vice President, People Jared Cohen, PhD, JD General Counsel Karla MacDonald Chief Corporate Affairs Officer Board of Directors Kush M. Parmar, MD, PhD Managing Partner, 5am Ventures (Board Chairman) Peter S. Kim, PhD Virginia & D.K. Ludwig Professor of Biochemistry, Stanford University Gina Chapman President and CEO, CARGO Therapeutics John F. Crowley Executive Chairman, Amicus Therapeutics Mary Thistle Industry Leader & Independent Director Bernhardt Zeiher, MD Industry Leader & Independent Director Dipal Doshi President and Chief Executive Officer